Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers

Xiaosong He, Barbara Rehermann, F. Xavier López-Labrador, Judie Boisvert, Ramsey Cheung, John Mumm, Heiner Wedemeyer, Marina Berenguer, Teresa L. Wright, Mark M. Davis, Harry B. Greenberg

Research output: Contribution to journalArticle

364 Citations (Scopus)

Abstract

It is believed that the hepatitis C virus (HCV)-specific CD8+ cytotoxic T lymphocytes (CTLs) play a role in the development of liver cell injury and in the clearance of the virus. To develop a direct binding assay for HCV- specific CTLs, we generated two peptide-MHC tetramers by using the recombinant HLA A2.1 molecule and A2-restricted T cell epitopes of the HEW NS3 protein. With these reagents we are able to detect specific CD8+ cells in the blood of 15 of 20 HLA-A2+, HCV-infected patients, at a frequency ranging from 0.01% to 1.2% of peripheral CD8+ T cells. Phenotypic analysis of these specific cells indicated that there is a significant variation in the expression of the CD45 isoforms and CD27 in different patients. A 6-hour incubation of one patient's blood with NS3 peptides resulted in the activation of the epitope-specific CD8+ cells, as indicated by their expression of CD69 and IFN-γ. We also detected NS3-specific CD8+ T cells in the intrahepatic lymphocyte population isolated from liver biopsies of two HCV-infected patients. The frequency of these specific CD8+ cells in the liver was 1-2%, at least 30-fold higher than in the peripheral blood. All of the intrahepatic NS3-specific CD8+ T cells were CD69+, suggesting that they were activated CTLs. Direct quantitation and characterization of HCV-specific CTLs should extend our understanding of the immunopathogenesis and the mechanism of clearance or persistence of HCV.

Original languageEnglish (US)
Pages (from-to)5692-5697
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume96
Issue number10
DOIs
StatePublished - May 11 1999
Externally publishedYes

Fingerprint

Hepacivirus
Cytotoxic T-Lymphocytes
T-Lymphocytes
Peptides
Liver
HLA-A2 Antigen
T-Lymphocyte Epitopes
varespladib methyl
Epitopes
Blood Cells
Protein Isoforms
Lymphocytes
Viruses
Biopsy
Wounds and Injuries
Population
Proteins

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. / He, Xiaosong; Rehermann, Barbara; López-Labrador, F. Xavier; Boisvert, Judie; Cheung, Ramsey; Mumm, John; Wedemeyer, Heiner; Berenguer, Marina; Wright, Teresa L.; Davis, Mark M.; Greenberg, Harry B.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 10, 11.05.1999, p. 5692-5697.

Research output: Contribution to journalArticle

He, X, Rehermann, B, López-Labrador, FX, Boisvert, J, Cheung, R, Mumm, J, Wedemeyer, H, Berenguer, M, Wright, TL, Davis, MM & Greenberg, HB 1999, 'Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers', Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 10, pp. 5692-5697. https://doi.org/10.1073/pnas.96.10.5692
He, Xiaosong ; Rehermann, Barbara ; López-Labrador, F. Xavier ; Boisvert, Judie ; Cheung, Ramsey ; Mumm, John ; Wedemeyer, Heiner ; Berenguer, Marina ; Wright, Teresa L. ; Davis, Mark M. ; Greenberg, Harry B. / Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. In: Proceedings of the National Academy of Sciences of the United States of America. 1999 ; Vol. 96, No. 10. pp. 5692-5697.
@article{1313d489128d4cbe8180b2e9853609a9,
title = "Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers",
abstract = "It is believed that the hepatitis C virus (HCV)-specific CD8+ cytotoxic T lymphocytes (CTLs) play a role in the development of liver cell injury and in the clearance of the virus. To develop a direct binding assay for HCV- specific CTLs, we generated two peptide-MHC tetramers by using the recombinant HLA A2.1 molecule and A2-restricted T cell epitopes of the HEW NS3 protein. With these reagents we are able to detect specific CD8+ cells in the blood of 15 of 20 HLA-A2+, HCV-infected patients, at a frequency ranging from 0.01{\%} to 1.2{\%} of peripheral CD8+ T cells. Phenotypic analysis of these specific cells indicated that there is a significant variation in the expression of the CD45 isoforms and CD27 in different patients. A 6-hour incubation of one patient's blood with NS3 peptides resulted in the activation of the epitope-specific CD8+ cells, as indicated by their expression of CD69 and IFN-γ. We also detected NS3-specific CD8+ T cells in the intrahepatic lymphocyte population isolated from liver biopsies of two HCV-infected patients. The frequency of these specific CD8+ cells in the liver was 1-2{\%}, at least 30-fold higher than in the peripheral blood. All of the intrahepatic NS3-specific CD8+ T cells were CD69+, suggesting that they were activated CTLs. Direct quantitation and characterization of HCV-specific CTLs should extend our understanding of the immunopathogenesis and the mechanism of clearance or persistence of HCV.",
author = "Xiaosong He and Barbara Rehermann and L{\'o}pez-Labrador, {F. Xavier} and Judie Boisvert and Ramsey Cheung and John Mumm and Heiner Wedemeyer and Marina Berenguer and Wright, {Teresa L.} and Davis, {Mark M.} and Greenberg, {Harry B.}",
year = "1999",
month = "5",
day = "11",
doi = "10.1073/pnas.96.10.5692",
language = "English (US)",
volume = "96",
pages = "5692--5697",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "10",

}

TY - JOUR

T1 - Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers

AU - He, Xiaosong

AU - Rehermann, Barbara

AU - López-Labrador, F. Xavier

AU - Boisvert, Judie

AU - Cheung, Ramsey

AU - Mumm, John

AU - Wedemeyer, Heiner

AU - Berenguer, Marina

AU - Wright, Teresa L.

AU - Davis, Mark M.

AU - Greenberg, Harry B.

PY - 1999/5/11

Y1 - 1999/5/11

N2 - It is believed that the hepatitis C virus (HCV)-specific CD8+ cytotoxic T lymphocytes (CTLs) play a role in the development of liver cell injury and in the clearance of the virus. To develop a direct binding assay for HCV- specific CTLs, we generated two peptide-MHC tetramers by using the recombinant HLA A2.1 molecule and A2-restricted T cell epitopes of the HEW NS3 protein. With these reagents we are able to detect specific CD8+ cells in the blood of 15 of 20 HLA-A2+, HCV-infected patients, at a frequency ranging from 0.01% to 1.2% of peripheral CD8+ T cells. Phenotypic analysis of these specific cells indicated that there is a significant variation in the expression of the CD45 isoforms and CD27 in different patients. A 6-hour incubation of one patient's blood with NS3 peptides resulted in the activation of the epitope-specific CD8+ cells, as indicated by their expression of CD69 and IFN-γ. We also detected NS3-specific CD8+ T cells in the intrahepatic lymphocyte population isolated from liver biopsies of two HCV-infected patients. The frequency of these specific CD8+ cells in the liver was 1-2%, at least 30-fold higher than in the peripheral blood. All of the intrahepatic NS3-specific CD8+ T cells were CD69+, suggesting that they were activated CTLs. Direct quantitation and characterization of HCV-specific CTLs should extend our understanding of the immunopathogenesis and the mechanism of clearance or persistence of HCV.

AB - It is believed that the hepatitis C virus (HCV)-specific CD8+ cytotoxic T lymphocytes (CTLs) play a role in the development of liver cell injury and in the clearance of the virus. To develop a direct binding assay for HCV- specific CTLs, we generated two peptide-MHC tetramers by using the recombinant HLA A2.1 molecule and A2-restricted T cell epitopes of the HEW NS3 protein. With these reagents we are able to detect specific CD8+ cells in the blood of 15 of 20 HLA-A2+, HCV-infected patients, at a frequency ranging from 0.01% to 1.2% of peripheral CD8+ T cells. Phenotypic analysis of these specific cells indicated that there is a significant variation in the expression of the CD45 isoforms and CD27 in different patients. A 6-hour incubation of one patient's blood with NS3 peptides resulted in the activation of the epitope-specific CD8+ cells, as indicated by their expression of CD69 and IFN-γ. We also detected NS3-specific CD8+ T cells in the intrahepatic lymphocyte population isolated from liver biopsies of two HCV-infected patients. The frequency of these specific CD8+ cells in the liver was 1-2%, at least 30-fold higher than in the peripheral blood. All of the intrahepatic NS3-specific CD8+ T cells were CD69+, suggesting that they were activated CTLs. Direct quantitation and characterization of HCV-specific CTLs should extend our understanding of the immunopathogenesis and the mechanism of clearance or persistence of HCV.

UR - http://www.scopus.com/inward/record.url?scp=13044313467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13044313467&partnerID=8YFLogxK

U2 - 10.1073/pnas.96.10.5692

DO - 10.1073/pnas.96.10.5692

M3 - Article

C2 - 10318946

AN - SCOPUS:13044313467

VL - 96

SP - 5692

EP - 5697

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 10

ER -